Home Axovant Sciences - The Late Clinical Stage Biotech With Huge IPO Potential
 

Keywords :   


Axovant Sciences - The Late Clinical Stage Biotech With Huge IPO Potential

2015-06-09 21:00:38| Biotech - Topix.net

Axovant Sciences is a late-stage clinical trial biotech preparing for its initial public offering the week of June 8. The company's lead drug candidate is an Alzheimer's treatment currently in Phase 3 trials. Axovant acquired the intellectual property and rights from GlaxoSmithKline .

Tags: potential late stage huge

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 7
05.11Tropical Storm Rafael Public Advisory Number 7
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 7
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
More »